REGENEREX PHARMA, INC. Retained Earnings
REGENEREX PHARMA, INC. had Retained Earnings of -$10.69 million as of 2025-12-31, per its 10-KT filed 2026-08-31.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-08-31
- 2025-12-31: Retained Earnings (Accumulated Deficit) -$10.69M.
- 2025-09-30: Retained Earnings (Accumulated Deficit) -$9.62M.
- 2025-06-30: Retained Earnings (Accumulated Deficit) -$8.81M.
- 2025-03-31: Retained Earnings (Accumulated Deficit) -$8.14M.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2025-12-31 | -$10.69M 10-KT · filed 2026-08-31 |
| 2025-09-30 | -$9.62M 10-Q · filed 2025-11-17 |
| 2025-06-30 | -$8.81M 10-Q · filed 2025-08-14 |
| 2025-03-31 | -$8.14M 10-KT · filed 2026-08-31 |
| 2024-12-31 | -$6.73M 10-Q · filed 2025-02-07 |
| 2024-09-30 | -$6.42M 10-Q · filed 2024-11-04 |
| 2024-06-30 | -$5.89M 10-Q · filed 2024-08-07 |
| 2024-03-31 | -$5.62M 10-K · filed 2025-06-30 |
| 2023-12-31 | -$5.32M 10-Q · filed 2024-02-05 |
| 2023-09-30 | -$5.06M 10-Q · filed 2023-11-08 |
| 2023-06-30 | -$2.26M 10-Q · filed 2023-08-14 |
| 2023-03-31 | -$2.07M 10-K · filed 2024-06-24 |
| 2022-12-31 | -$2.03M 10-Q · filed 2023-01-24 |
| 2022-09-30 | -$1.98M 10-Q · filed 2022-11-07 |
| 2022-06-30 | -$1.96M 10-Q · filed 2022-08-09 |
| 2022-03-31 | -$1.93M 10-K · filed 2023-06-09 |
| 2021-12-31 | -$1.89M 10-Q/A · filed 2022-02-03 |
| 2021-09-30 | -$1.81M 10-Q · filed 2021-11-01 |
| 2021-06-30 | -$1.77M 10-Q · filed 2021-08-12 |
| 2021-03-31 | -$1.74M 10-Q/A · filed 2022-02-03 |
| 2021-03-21 | -$1.74M 10-K · filed 2022-06-28 |
| 2020-12-31 | -$1.45M 10-Q · filed 2021-02-11 |
| 2020-09-30 | -$1.42M 10-Q · filed 2020-11-10 |
| 2020-06-30 | -$1.40M 10-Q · filed 2020-08-12 |
| 2020-03-31 | -$1.39M 10-K · filed 2021-06-23 |
| 2019-12-31 | -$1.35M 10-Q · filed 2020-02-10 |
| 2019-09-30 | -$1.32M 10-Q · filed 2019-10-30 |
| 2019-06-30 | -$1.31M 10-Q/A · filed 2019-07-29 |
| 2019-03-31 | -$1.27M 10-K/A · filed 2020-08-11 |
| 2018-12-31 | -$1.26M 10-Q · filed 2019-02-04 |
| 2018-09-30 | -$1.20M 10-Q · filed 2018-11-13 |
| 2018-06-30 | -$1.20M 10-Q · filed 2018-08-09 |
| 2018-03-31 | -$1.18M 10-K · filed 2019-06-24 |
| 2017-12-31 | -$1.17M 10-Q · filed 2018-02-08 |
| 2017-09-30 | -$1.16M 10-Q · filed 2017-11-07 |
| 2017-06-30 | -$1.15M 10-Q · filed 2017-08-07 |
| 2017-03-31 | -$1.13M 10-K · filed 2018-06-21 |
| 2014-11-30 | -$105.84K 10-K · filed 2015-03-03 |
| 2014-08-31 | -$105.84K 10-Q · filed 2014-10-20 |
| 2014-05-31 | -$105.84K 10-Q · filed 2014-07-23 |
| 2014-02-28 | -$105.84K 10-Q · filed 2014-04-11 |
| 2013-11-30 | -$105.84K 10-K · filed 2015-03-03 |
| 2012-11-30 | -$105.84K 10-K · filed 2014-02-28 |
| 2012-08-31 | -$105.84K 10-Q · filed 2012-10-15 |
| 2012-05-31 | -$105.84K 10-Q · filed 2012-07-16 |
| 2011-11-30 | -$105.84K 10-K · filed 2013-02-28 |
| 2011-08-31 | -$105.84K 10-Q · filed 2011-10-13 |
| 2010-11-30 | -$105.84K 10-K · filed 2012-02-28 |
| 2010-05-20 | $104.00K 10-K · filed 2015-03-03 |